Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda SC in Multiple European Markets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 124.83 +0.46 (0.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.37 | 52 Week High | $18.39 | |||
| Open | $123.90 | 52 Week Low | $6.96 | |||
| Day High | $125.43 | P/E | N/A | |||
| Day Low | $122.71 | EPS | $-0.58 | |||
| Volume | 1,740,095 | |||||
